Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell & Gene Therapy
Pharma
Bluebird bio lays off 25% of workforce
The layoff round means that nearly 100 bluebirds will have to leave the nest, with R&D and administration staffers bearing the brunt of the cuts.
Angus Liu
Sep 24, 2024 10:19am
Vertex adds CDMO Lonza to Casgevy production network
Sep 24, 2024 9:41am
Gilead's Kite exits China cell therapy JV with Fosun Pharma
Sep 19, 2024 4:23pm
Charles River looks to help bring Ori's CGT platform forward
Sep 18, 2024 8:01am
Astellas is closing down a gene therapy plant in California
Sep 4, 2024 12:46pm
BioMarin lays off 225 more staffers under new corporate strategy
Aug 29, 2024 4:30am
More News
Headhunter lays out leadership goals for CDMO industry
Aug 14, 2024 10:51am
Legend CEO talks BIOSECURE Act, M&A rumor and Carvykti growth
Aug 9, 2024 10:30am
BioMarin downsizes gene therapy efforts to focus on 3 markets
Aug 6, 2024 10:34am
FDA signs off on first engineered cell therapy for a solid tumor
Aug 2, 2024 8:56am
See more stories